Brief: Diasorin Q3 Net Profit EUR 38 Mln
05/11/2025 16:55
Nov 5 (Reuters) - DiaSorin SpA DIAS.MI: SEES FY 2025 ADJUSTED EBITDA MARGIN APPROX. 33% SEES FY 2025 EX-COVID REVENUES APPROX. +5%, APPROX. +4% INCLUDING COVID REVENUES Q3 NET PROFIT EUR 38 MLN Q3 ADJ EBITDA EUR 88 MLN Q3 REVENUE EUR 280 MLN Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest